Moreover, one of the main neuroinflammation biomarker used in clinical research is the 18-kDa translocator protein (TSPO), as it is overexpressed in many brain diseases, including Alzheimer’s disease [4, 14–16]. This evidence concerns the gene TSPO and early-onset autosomal dominant Alzheimer disease.